EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Stent expansion in calcified coronary chronic total occlusions: The impact of different stent platforms

Paola Scarparo iD, Thom Schermers, Riccardo Improta, Isabella Kardys, Jeroen Wilschut, Joost Daemen iD, Rutger-Jan Nuis, Wijnand K Den Dekker, Nicolas M Van Mieghem iD, Roberto Diletti iD

Catheterization and Cardiovascular Interventions · 2023-09 · 102 (3) · 451-463

DOI: 10.1002/ccd.30774 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, 2023-09. Written by Paola Scarparo and 9 co-authors. Institution: Department of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands. Major MEDLINE topics: Coronary Occlusion, Drug-Eluting Stents, Percutaneous Coronary Intervention, Coronary Artery Disease. 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objectives

To evaluate the stent expansion of the durable‐polymer Zotarolimus‐eluting stent (dp‐ZES), the durable‐polymer Everolimus‐eluting stent (dp‐EES), and the bioabsorbable‐polymer Sirolimus‐eluting stent (bp‐SES) in calcified coronary chronic total occlusions (CTO).

Background

The newer generation stents with ultrathin struts might raise concerns regarding reduced radial strength and higher stent recoil (SR) when implanted in calcified CTOs.

Methods

Between January 2017 and June 2021 consecutive patients with CTO undergoing percutaneous coronary intervention with dp‐ZES, dp‐EES, or bp‐SES were evaluated. The analysis was performed in calcific and in noncalcific CTOs. Quantitative coronary angiography analysis was used to assess diameter stenosis (DS), absolute and relative SR, absolute and relative focal SR, absolute and relative balloon deficit (BD), and absolute and relative focal BD. The primary endpoint was DS.

Results

A total of 213 CTOs were evaluated, 115 calcific CTOs (dp‐ZES:25, dp‐EES:29, bp‐SES:61) and 98 non‐calcific CTOs (dp‐ZES:41, dp‐EES:11, bp‐SES:46). In calcific CTOs, residual DS was lower in dp‐ZES than in dp‐EES and bp‐SES (−1.00% [−6.50–6.50] vs. 13.00% [7.0–19.00] vs. 15.00% [5.00–20.00]; p < 0.001). Dp‐ZES was also an independent predictor of residual DS ≤ 10% (OR 11.34, 95% CI 2.6–49.43, p = 0.001). Absolute and relative focal SR and absolute and relative SR were similar between dp‐ZES, dp‐EES, and bp‐SES ( p = 0.913, p = 0.890, p = 0.518, p = 0.426, respectively). In noncalcified CTOs, the residual DS was similar in the three groups ( p = 0.340). High relative focal SR was less frequent in dp‐ZES than in dp‐EES and in bp‐SES (19.5% vs. 54.5% vs. 37.0%; p < 0.048).

Conclusions

The three stent platforms demonstrated an overall low residual DS when implanted in CTOs. However, dp‐ZES was associated with the lowest residual DS and identified as independent predictor of residual DS ≤ 10% in patients with calcific CTOs. Dp‐ZES was associated with a lower incidence of high relative focal stent recoil, in noncalcific CTOs. Balloon deficit might be considerate as a surrogate for stent expansion in calcified CTOs.

Subjects

MeSH terms (MEDLINE)

Coronary OcclusionDrug-Eluting StentsPercutaneous Coronary InterventionCoronary Artery DiseaseHumansTreatment OutcomeEverolimusStentsPolymersAbsorbable ImplantsProsthesis DesignSirolimus

Author keywords

bioabsorbable-polymer sirolimus-eluting stentcalcificationscoronary chronic total occlusionsdurable-polymer everolimus-eluting stentdurable-polymer zotarolimus-eluting stentstent expansion

Substances

EverolimusPolymerszotarolimusSirolimus

Authors and institutions

  • Department of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.

ORCID profiles: Paola Scarparo, Joost Daemen, Nicolas M Van Mieghem, Roberto Diletti

Cite

APA

Scarparo, P., Schermers, T., Improta, R., Kardys, I., Wilschut, J., Daemen, J., Nuis, R. J., Den Dekker, W. K., Van Mieghem, N. M., & Diletti, R. (2023). Stent expansion in calcified coronary chronic total occlusions: The impact of different stent platforms. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30774

Vancouver

Scarparo P, Schermers T, Improta R, Kardys I, Wilschut J, Daemen J, et al. Stent expansion in calcified coronary chronic total occlusions: The impact of different stent platforms. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30774

BibTeX
@article{Scarparo2023,
  author = {Scarparo, Paola and Schermers, Thom and Improta, Riccardo and Kardys, Isabella and Wilschut, Jeroen and Daemen, Joost and Nuis, Rutger-Jan and Den Dekker, Wijnand K and Van Mieghem, Nicolas M and Diletti, Roberto},
  title = {Stent expansion in calcified coronary chronic total occlusions: The impact of different stent platforms},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30774}
}
Start for free →